Titan Biotech Limited (TITANBIO) Share Price

BSE · Healthcare · Biotechnology · ISIN INE150C01029

₹382.55+2.65 (+0.70%)

Key metrics

Market Cap
₹1,586 Cr
P/E Ratio
246.03
EPS
1.56
Book Value
43.94
P/B Ratio
8.71
ROE
16.46%
ROCE
17.99%
Debt / Equity
0.03
Net Margin
14.49%
Revenue Growth
31.79%
Profit Growth
38.8%
Dividend Yield
0.1%
52W High
₹555.65
52W Low
₹130.40
Market Cap Band
small cap
Face Value

Ratios computed from the annual results period ending 2026-03-31.

About Titan Biotech Limited

Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen and protein products, such as wheat hydrolysate protein, corn hydrolysate protein, bovine collagen peptide, collagen peptide, fish collage, undernatured chicken collagen type II, mucopolysaccharides, chicken protein isolate, soya protein isolate, and pea protein isolate; and brown rice protein, milk protein, protein hydrolysate, bovine cartilage extract, L-glutathione, cow colostrum powder, collagen peptides, whey protein, sodium caseinate, chondroitin sulphate, and hyaluronic acid. The company also provides coenzyme Q10, glucosamine KCL/HCL, methyl sulfonyl methane, chelated minerals, and peptone; OX bile extract, cholic acid, cerebroprotein hydrolysate, and iron protein succinylate; medicinal yeast and brewer yeast protein; and animal nutrition comprising mannan oligosaccharide, amino chelated mineral, sodium and calcium butyrate, sodium and calcium propionate, protein hydrolysate, and active dry yeast. In addition, it offers liver, meat, malt, and yeast extract. Its products are used in the pharmaceuticals, nutraceuticals, food and beverages, biotechnology and fermentation, cosmetics, veterinary and animal feed, agriculture industries, and microbiology and plant tissue culture media fields. The company also exports its products. Titan Biotech Limited was incorporated in 1992 and is based in New Delhi, India.

Headquarters
New Delhi, India
Promoter Holding
68.1%

The full Titan Biotech Limited analysis

Create a free account to open the complete TITANBIO deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.

  • 10-year financialsIncome statement, balance sheet and cash flow, year by year.
  • Valuation & fair valueFair-value estimates, quality scores and a value grade.
  • Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
  • Shareholding historyPromoter, FII, DII and public holdings across every quarter.
  • Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
  • Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.